The global corticosteroids market has experienced significant impacts due to the COVID-19 pandemic, with the healthcare systems worldwide being profoundly affected. Early in the pandemic, it was suggested that inhaled corticosteroids could be beneficial for individuals with asthma and Chronic obstructive pulmonary disease (COPD) as they exhibited a lower rate of COVID-19 infection. Furthermore, research from corticosteroid trials conducted a prospective meta-analysis of randomized trials for corticosteroid therapy for COVID-19, providing valuable insights and guidance for the development of treatment protocols. Notably, methylprednisolone demonstrated superior results to dexamethasone in hospitalized hypoxic COVID-19 patients. Consequently, the use of corticosteroids in the treatment of COVID-19 patients has increased significantly, creating substantial growth opportunities for the corticosteroids market during the forecast period of 2021-2031.
Get a Sample Copy of the Market Research Report (Use Corporate Mail Id for Quick Response) –https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=51582
The report by TMR Research on the corticosteroids market showcases extensive expertise in creating cutting-edge studies for various industries. The research report provides stakeholders and CXOs with valuable insights to make informed decisions, incorporating key trends, competitive analysis, regional viewpoints, restraints, and development impacting the growth of the corticosteroids market.